Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis

Cancer Research

Volumn 63, Issue 11, 2003, Pages 2864-2871

  Aldred, Micheala A ^a,b,c,e   Ginn Pease, Margaret E ^a,b,c   Morrison, Carl D ^a,b   Popkie, Anthony P ^a   Gimm, Oliver ^d   Hoang Vu, Cuong ^d   Krause, Ulf ^d   Dralle, Henning ^d   Jhiang, Sissy M ^a,b   Plass, Christoph ^a,b,c   Eng, Charis ^a,b,c,f  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 3B; CAVEOLIN 1; CAVEOLIN 2; CHORDIN; GLYPICAN; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CHROMOSOME 10Q; CHROMOSOME 7Q; CONGENITAL TUMOR; COWDEN SYNDROME; FEMALE; GENE EXPRESSION; GENE LOCATION; GENETIC PREDISPOSITION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IODINE DEFICIENCY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA, FOLLICULAR; BONE MORPHOGENETIC PROTEINS; CAVEOLIN 1; CAVEOLIN 2; CAVEOLINS; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID NEOPLASMS;

EID: 0037905722     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dahia, P. L., Marsh, D. J., Zheng, Z., Zedenius, J., Komminoth, P., Frisk, T., Wallin, G., Parsons, R., Longy, M., Larsson, C., and Eng, C. Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res., 57: 4710-4713, 1997.
2. Halachmi, N., Halachmi, S., Evron, E., Cairns, P., Okami, K., Saji, M., Westra, W. H., Zeiger, M. A., Jen, J., and Sidransky, D. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosomes Cancer, 23:239-243, 1998.
3. Yeh, J. J., Marsh, D. J., Zedenius, J., Dwight, T., Delbridge, L., Robinson, B. G., and Eng, C. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways. Genes Chromosomes Cancer, 26:322-328, 1999.
4. Grebe, S. K. G., McIver, B., Hay, I. D., Wu, P. S.-C., Maciel, L. M. Z., Drabkin, H. A., Goellner, J. R., Grant, C. S., Jenkins, R. B., and Eberhardt, N. L. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid cancer. J. Clin. Endocrinol. Metab., 82: 3684-3691, 1997.
5. Oriola, J., Halperin, I., Mallofré, C., Muntané, J., Angel, M., and Rivera-Fillat, F. Screening of selected genomic areas potentially involved in thyroid neoplasms. Eur. J. Cancer, 37: 2470-2474, 2001.
6. Trovato, M., Fraggetta, F., Villari, D., Batolo, D., Mackey, K., Trimarchi, F., and Benvenga, S. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer. J. Clin. Endocrinol. Metab., 84: 3235-3240, 1999.
7. Tung, W. S., Shevlin, D. W., Kaleem, Z., Tribune, D. J., Wells, S. A., Jr., and Goodfellow, P. J. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss. Genes Chromosomes Cancer, 19: 43-51, 1997.
8. Ward, L. S., Brenta, G., Medvedovic, M., and Fagin, J. A. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J. Clin. Endocrinol. Metab., 83: 525-530, 1998.
9. Zedenius, J., Wallin, G., Svensson. A., Bovée, J., Höög, A., Bäckdahl, M., and Larsson, C. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum. Genet., 97: 299-303, 1996.
10. Kroll, T. G., Sarraf, P., Pecciarini, L., Chen, C-J., Mueller, E., Spiegelman, B. M., and Fletcher, J. A. PAX8-PPARγl fusion oncogene in human thyroid carcinoma. Science. 289: 1357-1360, 2000.
11. Marques, A. R., Espadinha, C., Catarino, A. L., Moniz, S., Pereira, T., Sobrinho, L. G., and Leite, V. Expression of PAX8-PPARγl rearrangements in both follicular thyroid carcinomas and adenomas. J. Clin. Endocrinol. Metab., 87: 3947-3952, 2002.
12. Nikiforova, M. N., Biddinger, P. W., Caudill, C. M., Kroll, T. G., and Nikiforov, Y. E. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohisto-chemical analyses. Am. J. Surg. Pathol., 26: 1016-1023, 2002.
13. Schagdarsurengin, U., Gimm, O., Hoang-Vu, C., Dralle, H., Pfeifer, G. P., and Dammann, R. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res., 62: 3698-3701, 2002.
14. Zschocke, J., Manthey, D., Bayatti, N., van der Burg, B., Goodenough, S., and Behl, C. Estrogen receptor α-mediated silencing of caveolin gene expression in neuronal cells. J. Biol. Chem., 277: 38772-38780, 2002.
15. Aldred, M. A., Morrison, C., Gimm, O., Hoang-Vu, C., Krause, U., Dralle, H., Jhiang, S., and Eng, C. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas. Oncogene, in press, 2003.
16. Scherer, P. E., Tang, Z., Chun, M., Sargiacomo, M., Lodish, H. F., and Lisanti, M. P. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identificafion and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem., 270: 16395-16401, 1995.
17. Kogo, H., and Fujimoto, T. Caveolin-1 isoforms are encoded by distinct mRNAs. Identification of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett., 465: 119-123, 2000.
18. Engleman, J. A., Zhang, X. L., and Lisanti, M. P. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). FEBS Lett., 448: 221-230, 1999.
19. Ito, Y., Yoshida, H., Nakano, K., Kobayashi, K., Yokozawa, T., Hirai, K., Matsuzuka, F., Matsuura, N., Kakudo, K., Kuma, K., and Miyauchi, A. Caveolin-1 overexpression is an early event in the progression of papillary carcinoma of the thyroid. Br. J. Cancer, 86: 912-916, 2002.
20. Fujimoto, T., Kogo, H., Nomura, R., and Une, T. Isoforms of caveolin-1 and caveolar structure. J. Cell Sci., 113: 3509-3517, 2000.
21. Couet, J., Belanger, M. M., Roussel, E., and Drolet, M-C. Cell biology of caveolae and caveolin. Adv. Drug Delivery Rev., 49: 223-235, 2001.
22. Wiechen, K., Sers, C., Agoulnik, A., Arlt, K., Dietel, M., Schlag, P. M., and Schneider, U. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol., 158: 833-839, 2001.
23. Wiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K. M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P. D., Dietel, M., Schafer, R., and Sers, C. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol., 159: 1635-1643, 2001.
24. Cui, J., Rohr, L. R., Swanson, G., Speights, V. O., Maxwell, T., and Brothman, A. R. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate, 46: 249-256, 2001.
25. Fiucci, G., Ravid, D., Reich, R., and Liscovitch, M. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene, 21: 2365-2375, 2002.
26. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G., Di Vizio, D., Hou, H., Kneitz, B., Lagaud, G., Christ, G. J., Edelmann, W., and Lisanti, M. P. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem., 276: 38121-38138, 2001.
27. Hayashi, K., Matsuda, S., Machida, K., Yamamoto, T., Fukuda, Y., Nimura, Y., Hayakawa, T., and Hamaguchi, M. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res., 61: 2361-2364, 2001.
28. Lee, H., Park, D. S., Razani, B., Russell, R. G., Pestell, R. G., and Lisanti, M. P. Caveolin-1 mutations (P 132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am. J. Pathol., 161: 1357-1369, 2002.
29. Kato, K., Hida, Y., Miyamoto, M., Hashida, H., Shinohara, T., Itoh, T., Okushiba, S., Kondo, S., and Katoh, H. Overexpression of caveolin-1 in esopahgeal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer (Phila.), 94: 929-933, 2002.
30. Yang, G., Truong, L. D., Wheeler, T. M., and Thompson, T. C. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res., 59: 5719-5723, 1999.
31. Suzuoki, M., Miyamoto, M., Kato, K., Hiraoka, K., Oshikiri, T., Nakakubo, Y., Fukunaga, A., Shichinohe, T., Shinohara, T., Itoh, T., Kondo, S., and Katoh, H. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br. J. Cancer, 87: 1140-1144, 2002.
32. Ho, C. C., Huang, P. H., Huang, H. Y., Chen, Y. H., Yang, P. C., and Hsu, S. M., Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am. J. Pathol., 161: 1647-1656, 2002.
33. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., Schedl, A., Haller, H., and Kurzchalia, T. V. Loss of caveolae, vascular dysfunction and pulmonary defects in caveolin-1 genedisrupted mice. Science (Wash. DC), 293: 2449-2452, 2001.
34. Dai, Z., Lakshmanan, R. R., Zhu, W-G., Smiraglia, D. J., Rush, L. J., Frühwald, M. C., Brena, R. M., Li, B., Wright, F. A., Ross, P., Otterson, G. A., and Plass, C. Global methylation profiling of lung cancer identifies novel methylated genes. Neoplasia, 3: 314-323, 2001.
35. Xiang, Y. Y., Ladeda, V., and Filmus, J. Glypican-3 expression is silenced in human breast cancer. Oncogene, 20: 7408-7412, 2001.
36. Murthy, S. S., Shen, T., De Rienzo, A., Lee, W. C., Ferriola, P. C., Jhanwar, S. C., Mossman, B. T., Filmus, J., and Testa, J. R. Expression of GPC3, an X-linked recessive overgrowth gene, is silenced in malignant mesothelioma. Oncogene, 19: 410-416, 2000.
37. Zhu, Z., Friess, H., Kleeff, J., Wang, L., Wirtz, M., Zimmerman, A., Korc, M., and Buchler, M. W. Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer. Am. J. Surg., 184: 78-83, 2002.
38. Lin, H., Huber, R., Schlessinger, D., and Morin, P. J. Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res., 59: 807-810, 1999.
39. Huang, Y., Prasad, M., Lemon, W. J., Hampel, H., Wright, F. A., Kornacker, K., LiVolsi, V., Frankel, W., Kloos, R. T., Eng, C., Pellegata, N., and de la Chapelle, A. Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc. Natl. Acad. Sci. USA, 98: 15044-15049, 2001.
40. Cheng, F., Mani, K., van den Born, J., Ding, K., Belting, M., and Fransson, L. A. Nitric oxide-dependent processing of heparan sulfate in recycling S-nitrosylated glypican-1 takes place in caveolin-1-containing endosomes. J. Biol. Chem., 277: 44431-44439, 2002.
41. Yu, S., Matsusue, K., Kashireddy, P., Cao, W. Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J., and Reddy, J. K. Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to PPARg1 overexpression. J. Biol. Chem., 278: 498-505, 2002.
42. Gimm, O., Perren, A., Weng, L-P., Marsh, D. J., Yeh, J. J., Ziebold, U., Gil, E., Hinze, R., Delbridge, L., Lees, J. A., Mutter, G. L., Robinson, B. G., Komminoth, P., Dralle, H., and Eng, C. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am. J. Pathol., 156: 1693-1700, 2000.
43. Caselli, A., Mazzinghi, B., Camici, G., Manao, G., and Ramponi, G. Some protein tyrosine phosphastases target in part to lipid rafts and interact with caveolin-1. Biochem. Biophys. Res. Commun., 296: 692-697, 2002.